Table 2.

Microarray detection of autoantibodies in sera from patients with rheumatoid diseases.

AutoantibodySera positive for antibodies, n (%)
SLESSSScRAPM
dsDNA30/71 (42%)6/20 (30%)0/36 (0%)18/83 (22%)5/38 (13%)
SSA/6034/71 (48%)16/20 (80%)6/36 (17%)7/83 (8%)25/38 (66%)
U1snRNP19/71 (27%)0/20 (0%)0/36 (0%)0/83 (0%)0/38 (0%)
SSB20/71 (28%)6/20 (30%)7/36 (19%)2/83 (2%)6/38 (15%)
Jo-10/71 (0%)2/20 (10%)1/36 (3%)0/83 (0%)27/38 (71%)
CK198/71 (11%)6/20 (30%)1/36 (3%)9/83 (9%)4/38 (11%)
Scl-7018/71 (25%)0/20 (0%)15/36 (42%)2/82 (2%)0/38 (0%)
SSA/5238/71 (54%)8/20 (40%)12/36 (33%)1/83 (1%)7/38 (18%)
Sm18/71 (25%)0/20 (0%)0/36 (0%)0/83 (0%)0/38 (0%)
Histone14/71 (20%)4/20 (20%)10/36 (28%)4/83 (3%)2/38 (5%)
ssDNA35/71 (49%)2/20 (10%)6/36 (17%)6/83 (7%)4/38 (10%)
RF2/71 (3%)0/20 (0%)2/36 (6%)50/83 (60%)0/38 (0%)
CENP-B17/71 (24%)10/20 (50%)10/36 (28%)6/83 (7%)0/38 (0%)
CCP10/71 (14%)0/20 (0%)0/36 (0%)34/83 (41%)0/38 (0%)
ANA56/71 (79%)20/20 (100%)34/36 (94%)22/83 (26%)33/38 (87%)